Acumen Pharmaceuticals Files Q1 2025 10-Q
Ticker: ABOS · Form: 10-Q · Filed: May 13, 2025 · CIK: 1576885
| Field | Detail |
|---|---|
| Company | Acumen Pharmaceuticals, INC. (ABOS) |
| Form Type | 10-Q |
| Filed Date | May 13, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, biotech
TL;DR
Acumen Pharma's Q1 2025 10-Q is in. Check financials.
AI Summary
Acumen Pharmaceuticals, Inc. filed its 10-Q for the period ending March 31, 2025. The company, incorporated in Delaware, operates in the biological products sector. Its principal executive offices are located at 427 Park St., Charlottesville, VA.
Why It Matters
This filing provides investors with a quarterly update on Acumen Pharmaceuticals' financial health and operational status, crucial for understanding its performance in the biotechnology sector.
Risk Assessment
Risk Level: low — This is a standard quarterly financial filing with no immediate red flags or significant new disclosures.
Key Numbers
- 2025-03-31 — Reporting Period End Date (Indicates the end of the financial quarter being reported.)
- 2025-05-13 — Filing Date (The date the report was officially submitted to the SEC.)
Key Players & Entities
- Acumen Pharmaceuticals, Inc. (company) — Filer of the 10-Q
- 20250331 (date) — End of the reporting period
- 20250513 (date) — Filing date
- Charlottesville, VA (location) — Location of principal executive offices
FAQ
What is the primary business of Acumen Pharmaceuticals, Inc.?
Acumen Pharmaceuticals, Inc. is primarily involved in the Biological Products sector, specifically excluding diagnostic substances, as indicated by its SIC code [2836].
Where are Acumen Pharmaceuticals, Inc.'s principal executive offices located?
The company's principal executive offices are located at 427 Park St., Charlottesville, VA 22902.
What is the SEC file number for Acumen Pharmaceuticals, Inc.?
The SEC file number for Acumen Pharmaceuticals, Inc. is 001-40551.
For what period is this 10-Q filing?
This 10-Q filing is for the period ending March 31, 2025.
When was this 10-Q filing submitted to the SEC?
This 10-Q filing was submitted to the SEC on May 13, 2025.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 13, 2025 regarding Acumen Pharmaceuticals, Inc. (ABOS).